Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Multiregion Sequencing Reveals Intratumoral Diversity

DOI: 10.1158/2159-8290.CD-RW2012-035 Published April 2012
  • Article
  • Info & Metrics
  • PDF
Loading
  • Major finding: One tumor can contain unique mutations in distinct regions.

  • Concept: A single biopsy may not be representative of the entire tumor.

  • Impact: Intratumoral variation may confound prognostics and personalized medicine.

Single tumor biopsy samples are used to characterize the mutational landscape, identify biomarkers of treatment response, stratify patients, and inspire targeted therapies, but emerging evidence suggests that genomic instability and evolutionary forces may drive heterogeneity within tumors and thus render the information derived from single biopsy samples incomplete. Gerlinger and colleagues performed whole-exome sequencing and single-nucleotide polymorphism array analyses on DNA extracted from multiple regions within primary tumors and metastases of 4 patients with renal carcinoma who were participating in a phase II preoperative trial of everolimus. Phylogenetic analyses based on shared and unique mutations revealed that tumor evolution occurred in a branched, nonlinear manner, although the acquisition of different mutations within the same gene in separate regions indicated that convergent evolution also occurs. Strikingly, more than half of all somatic mutations or chromosomal aberrations identified were present only in one or several regions, suggesting that a single biopsy would not be representative of the entire tumor. Indeed, gene expression analysis revealed that regions within the same tumor were enriched for signatures associated with both a poor and a good prognosis, indicating that multiregion sampling may improve biomarker accuracy. Additionally, analysis of the mTOR pathway revealed that downstream targets were only activated in the regions harboring an MTOR mutation, suggesting that divergent signal transduction pathway activity within individual tumors may further confound biomarker analysis and underlie drug resistance. Although future studies will need to confirm whether this high degree of intratumoral variation exists in other tumor types, these findings imply that focusing on ubiquitous alterations may lead to more robust prognostic indicators and improved responses to targeted therapy. Understanding the mechanisms that contribute to such diversity may also enable focused strategies to limit tumor adaptation.

Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronoos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883–92.

Notes

Note: Research Watch is written by Cancer Discovery Science Writers. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://CDnews.aacrjournals.org.

  • ©2012 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 2 (4)
April 2012
Volume 2, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Multiregion Sequencing Reveals Intratumoral Diversity
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Multiregion Sequencing Reveals Intratumoral Diversity
Cancer Discov April 1 2012 (2) (4) 300; DOI: 10.1158/2159-8290.CD-RW2012-035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Multiregion Sequencing Reveals Intratumoral Diversity
Cancer Discov April 1 2012 (2) (4) 300; DOI: 10.1158/2159-8290.CD-RW2012-035
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Notes
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Cell-Intrinsic Programs Partition Nutrients in Tumor Microenvironment
  • Extrachromosomal DNA Can Promote Oncogene Transcription in Trans
  • Transient Rest Reverses Exhaustion of Chimeric Antigen Receptor T Cells
Show more Research Watch

Tumorigenesis

  • IFNγ Acts on Endothelial Cells to Promote Tumor Regression
  • UBE2O Inhibition Restores AMPKα2 Levels to Impair Tumorigenesis
  • Translation from Alternate Start Sites Enriches Oncogenic Proteins
Show more Tumorigenesis
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement